| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0140-6736(83)91793-2 |
| P698 | PubMed publication ID | 6131300 |
| P50 | author | Bridget Robinson | Q51547027 |
| David Hedley | Q54282536 | ||
| P2093 | author name string | B Jameson | |
| J G Watson | |||
| H E Kay | |||
| H M Clink | |||
| M H Depledge | |||
| A Barrett | |||
| R L Powles | |||
| S D Lawler | |||
| H Lumley | |||
| T J McElwain | |||
| G R Morgenstern | |||
| P J Dady | |||
| J Sloane | |||
| J Filshie | |||
| M Leigh | |||
| P2860 | cites work | Marrow Transplantation for Acute Nonlymphoblastic Leukemia in First Remission | Q28305230 |
| Bone-Marrow Ablation and Allogeneic Marrow Transplantation in Acute Leukemia | Q42244579 | ||
| THE PLACE OF BONE-MARROW TRANSPLANTATION IN ACUTE MYELOGENOUS LEUKÆMIA | Q61872449 | ||
| Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation | Q70149552 | ||
| Transplantation of marrow from an unrelated donor to a patient with acute leukemia | Q72145731 | ||
| Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation | Q72419264 | ||
| P433 | issue | 8325 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | leukemia | Q29496 |
| P304 | page(s) | 612-615 | |
| P577 | publication date | 1983-03-01 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Mismatched family donors for bone-marrow transplantation as treatment for acute leukaemia | |
| P478 | volume | 1 |
| Q73043636 | A low CD34+ cell dose results in higher mortality and poorer survival after blood or marrow stem cell transplantation from HLA-identical siblings: should 2 x 10(6) CD34+ cells/kg be considered the minimum threshold? |
| Q37175992 | A review of the current status and techniques of allogeneic bone marrow transplantation for treatment of leukaemia |
| Q39799610 | Advances in haploidentical stem cell transplantation |
| Q39643104 | Adverse reactions and interactions of cyclosporin |
| Q55515367 | Allogeneic Hematopoietic Cell Transplantation for Older Adults with Acute Myeloid Leukemia. |
| Q73687742 | Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial |
| Q39727820 | Allogeneic bone marrow transplantation in leukemia patients |
| Q38248427 | Allogeneic hematopoietic cell transplantation for acute myeloid leukemia during first complete remission: a clinical perspective |
| Q33769696 | Allogeneic transplantation from donors other than HLA-identical siblings |
| Q28080943 | Alternative Donor Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia |
| Q26799456 | Alternative Donor Transplantation for Acute Myeloid Leukemia |
| Q36488985 | Anti-CD45 radioimmunotherapy without TBI before transplantation facilitates persistent haploidentical donor engraftment |
| Q40162868 | Application of bone marrow transplantation in chronic granulocytic leukaemia. |
| Q40173209 | Bone Marrow Transplantation for Diseases of Childhood |
| Q93558439 | Bone marrow transplantation |
| Q39704199 | Bone marrow transplantation for CML. |
| Q40558263 | Bone marrow transplantation for acute lymphoblastic leukaemia |
| Q44723585 | Bone marrow transplantation from partially HLA-mismatched family donors for acute leukemia: single-center experience of 201 patients |
| Q37196929 | Changes in plasma fibronectin during allogeneic bone marrow transplantation |
| Q39738014 | Complications of cyclosporin therapy |
| Q36931642 | Current status of reduced-intensity allogeneic stem cell transplantation using alternative donors |
| Q36603208 | Cyclosporine--a model for the testing of bio-immunological reaction modifiers in man. |
| Q57704640 | Cyclosporine-induced renal dysfunction in experimental animals and humans |
| Q89125895 | Early Fever after Haploidentical Bone Marrow Transplantation Correlates with Class II HLA-Mismatching and Myeloablation but Not Outcomes |
| Q34298239 | Engraftment syndrome following hematopoietic stem cell transplantation |
| Q38742867 | Ex vivo T-cell depletion in allogeneic hematopoietic stem cell transplant: past, present and future. |
| Q35575711 | Expansion of allospecific regulatory T cells after anergized, mismatched bone marrow transplantation |
| Q51798540 | First Successful Haploidentical Stem Cell Transplantation in Romania. |
| Q34255634 | Genetically haploidentical stem cell transplantation for acute leukemia |
| Q38838264 | Halfway there: the past, present and future of haploidentical transplantation. |
| Q26750671 | Haploidentical Transplantation in Children with Acute Leukemia: The Unresolved Issues |
| Q36724916 | Haploidentical bone marrow and stem cell transplantation: experience with post-transplantation cyclophosphamide |
| Q40814253 | Haploidentical bone marrow transplantation for severe combined immunodeficiency disease using soybean agglutinin-negative, T-depleted marrow cells |
| Q45795174 | Haploidentical hematopoietic cell transplantation for adult acute myeloid leukemia: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. |
| Q38802389 | Haploidentical hematopoietic stem-cell transplantation in adults |
| Q88506035 | Haploidentical stem cell transplantation: T cell depleted and repleted |
| Q36854831 | Haploidentical transplantation for hematologic malignancies: where do we stand? |
| Q73398052 | Haploidentical vs autologous hematopoietic stem cell transplantation in patients with acute leukemia beyond first remission |
| Q37235006 | Hematopoietic SCT from partially HLA-mismatched (HLA-haploidentical) related donors |
| Q40091471 | Hepatic transplantation: the state of play |
| Q34491107 | IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease |
| Q35060682 | Improved early outcomes using a T cell replete graft compared with T cell depleted haploidentical hematopoietic stem cell transplantation. |
| Q35824950 | Infectious complications in cord blood and T-cell depleted haploidentical stem cell transplantation |
| Q35080323 | Influence of one human leukocyte antigen mismatch on outcome of allogeneic bone marrow transplantation from related donors |
| Q59360870 | Infusion of Alloanergized Donor Lymphocytes after CD34-selected Haploidentical Myeloablative Hematopoietic Stem Cell Transplantation |
| Q50881073 | Interstitial pneumonitis in acute leukemia patients submitted to T-depleted matched and mismatched bone marrow transplantation. |
| Q89965807 | Key Aspects of the Immunobiology of Haploidentical Hematopoietic Cell Transplantation |
| Q92071883 | Mechanisms of Graft-versus-Host Disease Prevention by Post-transplantation Cyclophosphamide: An Evolving Understanding |
| Q26797506 | Modern approaches to HLA-haploidentical blood or marrow transplantation |
| Q49566331 | NK cell therapy for hematologic malignancies |
| Q37978777 | New strategies for haploidentical transplantation |
| Q88633735 | Outcomes of hematopoietic stem cell transplantation from unmanipulated haploidentical versus matched sibling donor in patients with acute myeloid leukemia in first complete remission with intermediate or high-risk cytogenetics: a study from the Acut |
| Q36159937 | Overview of T-cell depletion in haploidentical stem cell transplantation |
| Q37740408 | Physicians' preferences and perceptions regarding donor selection in allogeneic stem cell transplantation in Korea when a matched domestic donor is not available |
| Q26852474 | Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantation |
| Q37915679 | Progress in haploidentical stem cell transplantation |
| Q26750995 | Recent advances in haploidentical hematopoietic stem cell transplantation using ex vivo T cell-depleted graft in children and adolescents |
| Q33841389 | Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT. |
| Q33382589 | Renal transplantation in patients with classical haemolytic-uraemic syndrome |
| Q43272332 | Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation |
| Q90305712 | Review of Haploidentical Hematopoietic Cell Transplantation |
| Q48101543 | Role of intensive care unit in a medical oncology department |
| Q52763837 | Role of αβ T Cell Depletion in Prevention of Graft versus Host Disease. |
| Q81247610 | Significance of one human leukocyte antigen mismatch on outcome of nonmyeloablative allogeneic stem cell transplantation from related donors using the Mexican schedule |
| Q91744792 | Similar transplant outcomes between haploidentical and unrelated donors after reduced-intensity conditioning with busulfan, fludarabine, and anti-thymocyte globulin in patients with acute leukemia or myelodysplastic syndrome |
| Q43029183 | Successful HLA haploidentical myeloablative stem cell transplantation for aggressive hepatosplenic alpha/beta (αβ) T-cell lymphoma. |
| Q43705421 | Successful rescue of early graft failure in pediatric patients using T-cell-depleted haploidentical hematopoietic SCT. |
| Q41956449 | Successful treatment with an unrelated-donor bone marrow transplant in an HLA-deficient patient with severe combined immune deficiency ("bare lymphocyte syndrome"). |
| Q38766552 | T Cell-Depleted and T Cell-Replete HLA-Haploidentical Stem Cell Transplantation for Non-malignant Disorders. |
| Q38212957 | T-cell replete haploidentical donor transplantation using post-transplant CY: an emerging standard-of-care option for patients who lack an HLA-identical sibling donor |
| Q34557915 | T-cell-replete haploidentical stem cell transplantation is highly efficacious for relapsed and refractory childhood acute leukaemia |
| Q44499719 | Thalidomide after allogeneic haematopoietic stem cell transplantation: activity in chronic but not in acute graft-versus-host disease |
| Q51847016 | The anaesthetic management of bone marrow harvest for transplantation |
| Q38032255 | The expanding frontier of hematopoietic cell transplantation |
| Q37806066 | The great debate: haploidentical or cord blood transplant |
| Q68606113 | The pathophysiology of Sandimmune (cyclosporine) in man and animals |
| Q42201176 | Thromboembolic complications and haemostatic changes in cyclosporin-treated cadaveric kidney allograft recipients |
| Q84588638 | Transplantation of CD6-depleted peripheral blood stem cells after DLA-haploidentical bone marrow transplantation contributes to engraftment and tolerance in a preclinical model of stem cell transplantation |
| Q75220822 | Transplantation of highly purified peripheral-blood CD34+ progenitor cells from related and unrelated donors in children with nonmalignant diseases |
| Q39816124 | Treatment of acute leukemia in adults with chemoradiotherapy and bone marrow transplantation |
Search more.